Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns

Carcinogenesis

Volumn 34, Issue 2, 2013, Pages 248-256

  Doig, Craig L ^a   Singh, Prashant K ^a   Dhiman, Vineet K ^a   Thorne, James L ^b   Battaglia, Sebastiano ^a   Sobolewski, Michelle ^a   Maguire, Orla ^a   O'Neill, Laura P ^c   Turner, Bryan M ^c   McCabe, Christopher J ^c   Smiraglia, Dominic J ^a   Campbell, Moray J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CALCITRIOL; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MESSENGER RNA; NUCLEAR RECEPTOR COREPRESSOR; PROTEIN BAX; PROTEIN NCOR1; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; UVOMORULIN; VITAMIN D RECEPTOR;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GENETIC CODE; HISTONE MODIFICATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION;

APOPTOSIS; BONE DENSITY CONSERVATION AGENTS; CALCITRIOL; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NUCLEAR RECEPTOR CO-REPRESSOR 1; PROMOTER REGIONS, GENETIC; PROSTATE; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CALCITRIOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84873564427     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs331     Document Type: Article

References (67)

1. Saramäki,A. et al, (2006) Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res., 34, 543-554.
2. Thorne,J.L. et al, (2011) Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in nonmalignant prostate cells. Nucleic Acids Res., 39, 2045-2056.
3. Métivier,R. et al, (2003) Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell, 115, 751-763.
4. Saramäki,A. et al, (2009) Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1alpha,25-dihydroxyvitamin D3. J. Biol. Chem., 284, 8073-8082.
5. Kang,Z. et al, (2004) Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol. Endocrinol., 18, 2633-2648.
6. Mohn,F. et al, (2009) Genetics and epigenetics: stability and plasticity during cellular differentiation. Trends Genet., 25, 129-136.
7. Fujita,N. et al, (2003) Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylationbased transcriptional repression. J. Biol. Chem., 278, 24132-24138.
8. Estève,P.O. et al, (2006) Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev., 20, 3089-3103.
9. Cheng,X. et al, (2010) Coordinated chromatin control: structural and functional linkage of DNA and histone methylation. Biochemistry, 49, 2999-3008.
10. Le May,N. et al, (2010) NER factors are recruited to active promoters and facilitate chromatin modification for transcription in the absence of exogenous genotoxic attack. Mol. Cell, 38, 54-66.
11. Métivier,R. et al, (2008) Cyclical DNA methylation of a transcriptionally active promoter. Nature, 452, 45-50.
12. Kangaspeska,S. et al, (2008) Transient cyclical methylation of promoter DNA. Nature, 452, 112-115.
13. Yoon,H.G. et al, (2003) N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol. Cell, 12, 723-734.
14. Battaglia,S. et al, (2010) Transcription factor co-repressors in cancer biology: roles and targeting. Int. J. Cancer, 126, 2511-2519.
15. Chen,J.D. et al, (1996) SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc. Natl. Acad. Sci. U.S.A., 93, 7567-7571.
16. Goodson,M.L. et al, (2005) Alternative mRNA splicing of SMRT creates functional diversity by generating corepressor isoforms with different affinities for different nuclear receptors. J. Biol. Chem., 280, 7493-7503.
17. Battaglia,S. et al, (2010) Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion. Carcinogenesis, 31, 1650-1660.
18. Altintas,D.M. et al, (2011) Cell cycle regulated expression of NCoR might control cyclic expression of androgen responsive genes in an immortalized prostate cell line. Mol. Cell. Endocrinol., 332, 149-162.
19. Girault,I. et al, (2003) Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen. Clin. Cancer Res., 9, 1259-1266.
20. Khanim,F.L. et al, (2004) Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Oncogene, 23, 6712-6725.
21. Banwell,C.M. et al, (2006) Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. Clin. Cancer Res., 12(7 Pt 1), 2004-2013.
22. Abedin,S.A. et al, (2009) Elevated NCOR1 disrupts a network of dietarysensing nuclear receptors in bladder cancer cells. Carcinogenesis, 30, 449-456.
23. Kim,J.Y. et al, (2009) Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor. Mol. Endocrinol., 23, 251-264.
24. Zhang,Z. et al, (2006) NCOR1 mRNA is an independent prognostic factor for breast cancer. Cancer Lett., 237, 123-129.
25. Chang,T.H. et al, (2002) Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung. Clin. Cancer Res., 8, 1206-1212.
26. Stephens,P.J. et al, (2012) The landscape of cancer genes and mutational processes in breast cancer. Nature, 486, 400-404.
27. Liao,G. et al, (2003) Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT. J. Biol. Chem., 278, 5052-5061.
28. Hodgson,M.C. et al, (2005) The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists. J. Biol. Chem., 280, 6511-6519.
29. Webber,M.M. et al, (1997) Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells. Carcinogenesis, 18, 1225-1231.
30. Kaighn,M.E. et al, (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest. Urol., 17, 16-23.
31. Campbell,M.J. et al, (1997) Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. J. Mol. Endocrinol., 19, 15-27.
32. Campbell,M.J. et al, (2000) The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression. Oncogene, 19, 5091-5097.
33. Matilainen,M. et al, (2005) Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3. Nucleic Acids Res., 33, 5521-5532.
34. Towsend,K. et al, (2006) Identification of VDR-responsive gene signatures in breast cancer cells. Oncology, 71, 111-123.
35. Chêne,G. et al, (2007) n-3 and n-6 polyunsaturated fatty acids induce the expression of COX-2 via PPARgamma activation in human keratinocyte HaCaT cells. Biochim. Biophys. Acta, 1771, 576-589.
36. Seuter,S. et al, (2007) Functional characterization of vitamin D responding regions in the human 5-Lipoxygenase gene. Biochim. Biophys. Acta, 1771, 864-872.
37. Qiu,X. et al, (2006) Assessing stability of gene selection in microarray data analysis. BMC Bioinformatics, 7, 50.
38. Camoriano,M. et al, (2008) Phenotype-specific CpG island methylation events in a murine model of prostate cancer. Cancer Res., 68, 4173-4182.
39. Coolen,M.W. et al, (2007) Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res., 35, e119.
40. Ehrich,M. et al, (2005) Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc. Natl. Acad. Sci. U.S.A., 102, 15785-15790.
41. Zella,L.A. et al, (2007) Enhancers located in the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. J. Steroid Biochem. Mol. Biol., 103, 435-439.
42. Lakshmikuttyamma,A. et al, (2010) Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition. Oncogene, 29, 576-588.
43. Cherrier,T. et al, (2009) p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1. Oncogene, 28, 3380-3389.
44. Thorne,J. et al, (2008) The vitamin D receptor in cancer. Proc. Nutr. Soc., 67, 115-127.
45. Saramaki,A., et al, (2009) Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1alpha,25-dihydroxyvitamin D3. J. Biol. Chem., 284, 8073-8082.
46. Pollard,P.J. et al, (2008) Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha. Biochem. J., 416, 387-394.
47. Toropainen,S. et al, (2010) The down-regulation of the human MYC gene by the nuclear hormone 1alpha,25-dihydroxyvitamin D3 is associated with cycling of corepressors and histone deacetylases. J. Mol. Biol., 400, 284-294.
48. Colston,K. et al, (1981) 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology, 108, 1083-1086.
49. Miyaura,C. et al, (1981) 1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem. Biophys. Res. Commun., 102, 937-943.
50. Abe,E. et al, (1981) Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc. Natl. Acad. Sci. U.S.A., 78, 4990-4994.
51. Campbell,M.J. et al, (1997) Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. J. Mol. Endocrinol., 19, 15-27.
52. Elstner,E. et al, (1999) Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells. Prostate, 40, 141-149.
53. Peehl,D.M. et al, (1994) Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res., 54, 805-810.
54. Colston,K. et al, (1982) 1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines. Cancer Res., 42, 856-859.
55. Blutt,S.E. et al, (2000) A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice. Cancer Res., 60, 779-782.
56. Banach-Petrosky,W. et al, (2006) Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1;Pten mutant mice. Clin. Cancer Res., 12, 5895-5901.
57. Garland,C.F. et al, (1980) Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol., 9, 227-231.
58. Garland,F.C. et al, (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev. Med., 19, 614-622.
59. Luscombe,C.J. et al, (2001) Prostate cancer risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes. Br. J. Cancer, 85, 1504-1509.
60. Giovannucci,E. (2005) The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control, 16, 83-95.
61. Schwartz,G.G. et al, (1990) Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res., 10(5A), 1307-1311.
62. John,E.M. et al, (2005) Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res., 65, 5470-5479.
63. Chen,T.C. et al, (2003) Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer. J. Cell. Biochem., 88, 315-322.
64. Hsu,J.Y. et al, (2001) Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition. Cancer Res., 61, 2852-2856.
65. Ahonen,M.H. et al, (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control, 11, 847-852.
66. Albertson,D.G. et al, (2000) Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet., 25, 144-146.
67. Pálmer,H.G. et al, (2004) The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat. Med., 10, 917-919.